Drug Profile
Remifentanil
Alternative Names: Aruchiba; GI 87084; GI 87084B; GR 87084; JNJ-268229; Remifentanil hydrochloride; Remifentanyl; UltivaLatest Information Update: 01 Dec 2021
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer Abbott Laboratories; GSK; Janssen Pharmaceutical KK; Perrigo
- Class Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Anaesthesia; Pain